Accelerating Clinical Trials in the EU (ACT EU) Multi-Annual Workplan 2022-2026

On 2 September the EMA published the updated ACT EU multi-annual workplan.

The ACT EU 2022 – 2026 multi-annual workplan was adopted in August 2022 and introduces each of the priority actions and outlines their key deliverables. The workplan is anchored in the recommendations of the European Medicines Regulatory Network (EMRN) strategy to 2025 and the European Commission’s Pharmaceutical Strategy for Europe. The plan builds on the entry into application of the Clinical Trials Regulation (Regulation (EU) No 536/2014) and the activities already underway in the European regulatory network to support clinical trials. The workplan highlights key focus areas to further facilitate innovation in clinical trials, stakeholder engagement and regulatory network collaboration.

Read the pdf 
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /